Viene somministrato una volta alla settimana tramite iniezione sottocutanea ed indicato per pazienti con un indice di massa corporea (IMC) di 30 o superiore, o di 27 o superiore con almeno una comorbidit correlata al peso (come ipertensione o diabete di tipo 2)
Sold under names like Wegovy or Ozempic, Semaglutide mimics a hormone called GLP-1 that helps regulate hunger and blood sugar
The treatment is administered via a once-weekly subcutaneous injection, typically in the abdomen or thigh
Organizations like the American Diabetes Association and the Obesity Society have shared guidelines to help determine when its appropriate for patients to start treatments like this, but there isnt a playbook for managing limited supply, she said
Sobo to discuss GLP-1 therapy, semaglutide, tirzepatide, metabolic health, and physician-supervised weight loss options